Literature DB >> 8569187

Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.

S Chubinskaya1, K Huch, K Mikecz, G Cs-Szabo, K A Hasty, K E Kuettner, A A Cole.   

Abstract

The loss of aggrecan from articular cartilage may lead to the development of osteoarthritis (OA). Degradation products of human aggrecan, generated in vivo by enzymatic cleavages, have been identified in synovial fluid of patients with rheumatoid arthritis and OA. One matrix metalloproteinase (MMP), stromelysin (MMP-3), and an unidentified proteinase called "aggrecanase" are believed to generate these products in pathologic conditions. Thus far, only one proteinase, neutrophil collagenase (MMP-8), has been shown in vitro to be capable of cleavage of the aggrecan molecule at the "aggrecanase" site. In this study, we compare the presence and distribution of MMP-3 and MMP-8 in cartilages from two different joints of normal human donors. We determined whether mRNA for MMP-8 is expressed in normal human articular cartilage from different joints. In addition, we compared differences in MMP-8 and MMP-3 gene expression between human ankle and knee cartilage after in vitro stimulation by interleukin (IL)-1 beta. These two joints were chosen because the incidence of symptomatic and radiographic OA varies between the different joints. The knee is the most frequently involved joint, whereas the ankle (talocrural) joint is relatively rarely affected. Message for MMP-8 was detected in untreated cartilage from normal knee joints, but not in untreated cartilage of normal ankle joints. Message for MMP-3 was detectable in most of the knee and ankle cartilages. Messenger RNA expression for both MMPs could be up-regulated by IL-1 beta. The highest doses of IL-1 beta appeared to be most effective in stimulation of mRNA for MMP-3, whereas MMP-8 expression was more sensitive to lower doses of IL-1 beta. The fact that ankle cartilage with a low incidence of OA does not express MMP-8, whereas knee cartilage with a high incidence of OA does not express MMP-8, whereas knee cartilage with a high incidence of OA does constitutively express MMP-8, suggests that MMP-8 might be one of the key enzymes in the pathogenesis of osteoarthritis. This is further supported by our finding that the earliest signs of cartilage degradation were very similar to those found in IL-1 beta-treated explants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8569187

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Age-related changes in the expression of gelatinase and tissue inhibitor of metalloproteinase genes in mandibular condylar, growth plate, and articular cartilage in rats.

Authors:  Ichiro Takahashi; Kazuyuki Onodera; Jin-Wan Bae; Hidetoshi Mitani; Yasuyuki Sasano; Hideo Mitani
Journal:  J Mol Histol       Date:  2005-10-06       Impact factor: 2.611

2.  CORR Insights(®): The Natural History of Osteoarthritis: What Happens to the Other Hip?

Authors:  Hugo Armando Rodriguez
Journal:  Clin Orthop Relat Res       Date:  2016-06-21       Impact factor: 4.176

Review 3.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

Authors:  D J Schroen; C E Brinckerhoff
Journal:  Gene Expr       Date:  1996

4.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific.

Authors:  A J Freemont; V Hampson; R Tilman; P Goupille; Y Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

5.  Variations in chondrocyte apoptosis may explain the increased prevalence of osteoarthritis in some joints.

Authors:  C M Thomas; C E Whittles; C J Fuller; M Sharif
Journal:  Rheumatol Int       Date:  2010-04-16       Impact factor: 2.631

6.  Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.

Authors:  L D Kozaci; C J Brown; C Adcocks; A Galloway; A P Hollander; D J Buttle
Journal:  Mol Pathol       Date:  1998-10

Review 7.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

Review 8.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

Review 9.  Operative Treatment for Osteochondral Lesions of the Talus: Biologics and Scaffold-Based Therapy.

Authors:  Youichi Yasui; Adi Wollstein; Christopher D Murawski; John G Kennedy
Journal:  Cartilage       Date:  2016-05-09       Impact factor: 4.634

10.  Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.

Authors:  Ali A El-Solh; Daniel Amsterdam; Ahmad Alhajhusain; Morohonfolu E Akinnusi; Ranime G Saliba; Susan V Lynch; Jeanine P Wiener-Kronish
Journal:  J Infect       Date:  2009-05-23       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.